BILL · 2005–06 SESSION
SB 6623: Chemotherapy/anticancer drug
Creating a business and occupation tax exemption for chemotherapy and anticancer drugs dispensed pursuant to prescription.
Summary
- An exemption from B&O tax is provided for amounts derived from sales of prescription chemotherapy and anticancer drugs for infusion or injection for human use, if the drugs are sold for an amount not exceeding the rate at or below which the federal government reimburses under Medicare.
From the Senate Bill Report (SB 6623), written by the Legislature's nonpartisan staff. Read the full report ↗
Did not pass Did not pass · died in committee
- IntroducedJan 17, 2006
- Out of committeestopped here
- Passed Senate
- Passed House
- Governor
- Law
- Prime sponsor
- Margarita Prentice (D-11)
- Introduced
- January 17, 2006 in the Senate
- Last action
- January 17, 2006
- Companion bill
- HB 3086
- Budget
- Has a fiscal note
AN ACT Relating to business and occupation tax exemption for chemotherapy and anticancer drugs dispensed pursuant to prescription;
Sponsors
Prime sponsor: Margarita Prentice (D-11)
10 co-sponsors (5 Democrats, 5 Republicans)
Votes
No recorded floor votes. This measure never reached a floor vote.
History
- First reading, referred to Ways & Means.
SB 6623 in other sessions
Bill numbers restart every two years, so the same number is a different bill in each session.
- SB 6623 (2019–20) Host home funding
- SB 6623 (2017–18) Retail pet stores
- SB 6623 (2015–16) Transportation prop. rental
- SB 6623 (2011–12) Tobacco
- SB 6623 (2009–10) Persons w/ dev. disabilities
- SB 6623 (2007–08) Temporary medical housing
- SB 6623 (2003–04) Employer-owned life ins
- SB 6623 (2001–02) Consumer mortgage lending